Upgrade to SI Premium - Free Trial

Canaccord Starts Biohaven Pharma (BHVN) at Buy

April 13, 2026 5:18 AM
Canaccord analyst Sumant Kulkarni initiates coverage on Biohaven Pharma (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage